Delaying disease progression in COPD with early escalation to triple therapy: a modelling study (DEPICT-2)通过早期升级至三联疗法延缓COPD疾病进展:一项模型研究(DEPICT-2)ERJ OPEN RESEARCHIF42024-08-220OA
Pharmacological Basis of Differences in Dose Response, Dose Equivalence, and Duration of Action of Inhaled CorticosteroidsADVANCES IN THERAPYIF42024-03-272OAAI
Assessing the Effects of Changing Patterns of Inhaled Corticosteroid Dosing and Adherence with Fluticasone Furoate and Budesonide on Asthma Management (vol 40, pg 4042, 2023)ADVANCES IN THERAPYIF42023-10-070OAAI
DElaying Disease Progression In COPD with Early Initiation of Dual Bronchodilator or Triple Inhaled PharmacoTherapy (DEPICT): A Predictive Modelling Approach (Jun, 10.1007/s12325-023-02583-1, 2023)ADVANCES IN THERAPYIF42023-07-280OAAI
Assessing the Effects of Changing Patterns of Inhaled Corticosteroid Dosing and Adherence with Fluticasone Furoate and Budesonide on Asthma ManagementADVANCES IN THERAPYIF42023-07-125OAAI
DElaying Disease Progression In COPD with Early Initiation of Dual Bronchodilator or Triple Inhaled PharmacoTherapy (DEPICT): A Predictive Modelling ApproachADVANCES IN THERAPYIF42023-06-299OAAI
Comparative clinical pharmacology of mometasone furoate, fluticasone propionate and fluticasone furoatePULMONARY PHARMACOLOGY & THERAPEUTICSIF2.82022-12-011PRE
Inhaled glucocorticoid-induced metabolome changes in asthmaEUROPEAN JOURNAL OF ENDOCRINOLOGYIF5.22022-09-0110OAAI
New Versus Old: The Impact of Changing Patterns of Inhaled Corticosteroid Prescribing and Dosing Regimens in Asthma Management (vol 39, pg 1895, 2022)ADVANCES IN THERAPYIF42022-06-181OAAI
New Versus Old: The Impact of Changing Patterns of Inhaled Corticosteroid Prescribing and Dosing Regimens in Asthma ManagementADVANCES IN THERAPYIF42022-03-1424OAAI
Pharmacology Versus Convenience: A Benefit/Risk Analysis of Regular Maintenance Versus Infrequent or As-Needed Inhaled Corticosteroid Use in Mild AsthmaADVANCES IN THERAPYIF42021-12-0716OAAI
Intranasal Corticosteroids: Topical Potency, Systemic Activity and Therapeutic IndexJOURNAL OF ASTHMA AND ALLERGYIF32021-09-0117OAAI
A novel approach to improve detection of glucocorticoid doping in sport with new guidance for physicians prescribing for athletesBRITISH JOURNAL OF SPORTS MEDICINEIF16.22021-04-2015PRE
Inhaled corticosteroid (ICS) induced metabolome changes in asthmaticsEUROPEAN RESPIRATORY JOURNALIF212020-10-281PRE
Therapeutic index of inhaled corticosteroids in asthma: A dose-response comparison on airway hyperresponsiveness and adrenal axis suppressionBRITISH JOURNAL OF CLINICAL PHARMACOLOGYIF32020-06-1742OAAI
Late Breaking Abstract - Dose responses for topical efficacy and systemic activity, dose equivalence and relative therapeutic index for fluticasone furoate (FF), fluticasone propionate (FP) and budesonide (BUD) in asthmatic subjectsEUROPEAN RESPIRATORY JOURNALIF212019-11-213PRE
Hair analysis to monitor adherence to prescribed chronic inhaler drug therapy in patients with asthma or COPDPULMONARY PHARMACOLOGY & THERAPEUTICSIF2.82018-08-0129OAAI
Late Breaking Abstract - The duration of anti-inflammatory action of fluticasone furoate (FF) assessed via exhaled nitric oxide (FeNO) in asthmatics following administration of FF/vilanterol (VI)EUROPEAN RESPIRATORY JOURNALIF212017-12-061PRE
Hair analysis to detect chronic inhaler drug use in asthma or COPD patientsEUROPEAN RESPIRATORY JOURNALIF212017-12-060PRE
Inhaled corticosteroids: potency, dose equivalence and therapeutic indexBRITISH JOURNAL OF CLINICAL PHARMACOLOGYIF32015-05-28201OAAI